Mauna Kea (MKEAF) 4.8700 $MKEAF Mauna Kea Technologies

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mauna Kea (MKEAF) 4.8700 $MKEAF

Mauna Kea Technologies Obtains Regulatory Approval for the Commercialization of Cellvizio® in Mexico
PR Newswire - Mon Apr 20, 11:42AM CDT
-- Mexico is the second largest medical device market in Latin America after Brazil

Mauna Kea Technologies Reports Record Attendance at ICCU 2015 and at the Associated Post-graduate Course on Endomicroscopy
PR Newswire - Wed Apr 15, 11:00AM CDT
-- 300 physicians and surgeons gathered in Lisbon at the International Conference of Cellvizio Users to discuss advancements and benefits of endomicroscopy in multiple medical and surgical indications

Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform
PR Newswire - Tue Mar 31, 12:21PM CDT
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced the set-up of an optical biopsy program at the CHU de Grenoble (university hospital center). The CHU de Grenoble is now the first hospital in France to propose to its gastroenterology, interventional pulmonology and urology patients an innovative platform for clinical research and a higher standard of care thanks to the endomicroscopy technology developed by Mauna Kea Technologies.

Mauna Kea Technologies Announces Publication of Confirmation Data on the Value of Endomicroscopy for the Characterization of Pancreatic Cystic Neoplasms
PR Newswire - Wed Mar 25, 12:00PM CDT
Investigator-Initiated DETECT Study shows benefits of using Cellvizio to safely differentiate the nature of pancreas cysts with high specificity and accuracy

Baptist Medical Center in Florida Adopts Endomicroscopy with Cellvizio to Improve Care for Patients with Biliary and Pancreatic Diseases
PR Newswire - Mon Mar 23, 2:03PM CDT
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced that Baptist Medical Center in Jacksonville, Florida, a leading medical center in the southeastern United States, has adopted the Cellvizio technology platform to perform enhanced procedures in the field of biliary and pancreatic disorders including probe-based confocal laser endomicroscopy (pCLE) and needle-based confocal laser endomicroscopy (nCLE).

Leading 100 Medical Devices/Technology/Supplies Companies of Europe 2015
M2 - Mon Mar 23, 10:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wfwcrh/europe_medical) has announced the addition of the "Europe Medical Devices/Technology/Supplies 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Medical technology is a key driver for Europe's economic well-being, providing quality employment, and a substantial contribution to Europe's balance of trade. The European medical technology market is estimated at roughly 100 billion and is the second largest medical technology market after US. It has been growing on average by 4% per annum over the past 6 years. Through its healthcare innovations, the European medical device industry contributes to ensuring sustainable and accessible healthcare systems throughout Europe. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the European companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of Europe - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among European medical devices/technology/supplies companies - International presence of European medical devices/technology/supplies companies - R&D activities by European medical devices/technology/supplies companies Report Includes Companies Engaged in: - Manufacturing medical equipments providing any medical activity and/or treatment - Manufacturing diagnostic equipments - Manufacturing high-tech medical instruments - Manufacturing life-support medical equipments - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products - Manufacturing and/or selling basic medical and surgical materials (consumables), low-tech items and items used in medical equipment processor or for treating patients - Diagnostic equipment supplies - Medical supplies invasive and medical supplies non invasive - Manufacturing/supplying replaceable lenses for equipments - Manufacturing/supplying any item which needs to be replaced as a function of repeated medical activity or where need for treatments is constant - Manufacturing/supplying surgical and dental instruments, elective laser surgery equipments, orthopedic products, and other such products Companies Mentioned - Ion Beam Applications SA (Belgium) - Kitron ASA (Norway) - LiDCO Group PLC (United Kingdom) - MagForce AG (Germany) - Mauna Kea Technologies SAS (France) - Medica AD Sofia (Bulgaria) - Medicrea International (France) - Medisana AG (Germany) - Mercator Medical SA (Poland) - Nobel Biocare Holding AG (Switzerland) - Omega Diagnostics Group Plc (United Kingdom) - Orthofix International N.V. (Netherlands Antilles) - PuriCore PLC (United Kingdom) - PZ Cormay SA (Poland) - Sorin SpA (Italy) - Stentys (France) - Surgical Innovations Group PLC (United Kingdom) - Technoflex SA (France) - Voxel S.A. (Poland) For more information visit http://www.researchandmarkets.com/research/wf...pe_medical
OFIX: 32.54 (+0.21)

Mauna Kea Technologies Receives Additional CPT® Reimbursement Code in the U.S. Supporting Key Application of Endomicroscopy with Cellvizio in the Biliary Tract
PR Newswire - Tue Mar 17, 1:02PM CDT
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced that the American Medical Association (AMA) Editorial Panel has awarded a new CPT Code related to the use of endomicroscopy during endoscopic retrograde cholangiopancreatography (ERCP) procedures to enable physicians to diagnose health problems in the biliary tract including diagnosis of biliary strictures and the presence of biliary cancer. More than 500,000 ECRPs are completed annually in the United States.

Mauna Kea Technologies Announces Acceleration of Installations and Use of Cellvizio Endomicroscopy Platform in Japan
PR Newswire - Wed Mar 11, 6:46PM CDT
Technology highlighted in first-ever Japanese live demonstration during the 14th Yokohama International Endoscopy Conference.

Mauna Kea Technologies Announces Positive Results from FOCUS Pivotal Clinical Trial on Use of Confocal Laser Endomicroscopy in Biliary Cancer Detection
PR Newswire - Tue Jan 27, 10:45AM CST
Results published in peer-reviewed journal Gastrointestinal Endoscopy accompanied by editorial noting that the study "pushes the boundaries of diagnosis in indeterminate biliary strictures"

Mauna Kea Technologies Announces Publication of Consensus Report Based on Clinical Evidence on Use of Confocal Laser Endomicroscopy in Gastroenterology
PR Newswire - Tue Jan 20, 10:45AM CST
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced publication of the first consensus recommendations on the clinical use of probe-based confocal laser endomicroscopy (pCLE) in gastrointestinal applications, by the peer-reviewed journal United European Gastroenterology. The recommendations were presented in an article entitled: "Use of probe-based confocal laser endomicroscopy (pCLE) in gastrointestinal applications: a consensus report based on clinical evidence", authored by 26 international experts in gastroenterology and confocal laser endomicroscopy.

Mauna Kea Technologies: Editorial Highlighting Advantages of Needle-based Endomicroscopy for Characterization of Pancreatic Cysts Published in Endoscopy
PR Newswire - Wed Jan 14, 11:30AM CST
-- Editorial accompanies publication of CONTACT 1 Study results showing that needle-based confocal laser endomicroscopy with Cellvizio able to confirm benign serous cystadenomas with 100% specificity.

Mauna Kea Technologies Announces 2014 Sales Growth of +10% to EUR 11.0m
PR Newswire - Wed Jan 07, 11:00AM CST
-- Strong growth in Asia-Pacific region: +52%

Mauna Kea Technologies and Siemens Announce Joint Effort to Evaluate the Use of Cellvizio in Interventional Radiology
PR Newswire - Mon Nov 03, 12:27PM CST
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the unique trans-disciplinary optical biopsy platform, today announced a new collaboration with Siemens Healthcare to evaluate the clinical benefits of Cellvizio® in interventional radiology procedures. Cellvizio's needle-based optical biopsy technology will be used in combination with Siemens Angiography & Interventional X-ray (AX) and Computed Tomography (CT) imaging systems in two clinical studies taking place at the Hôpital Européen Georges Pompidou (HEGP) in Paris and the University Hospital in Strasbourg, France.

Surgeons at Coliseum Northside Hospital Among First in Nation to use Endomicroscopic Imaging With Cellvizio to Identify Esophageal Disease Prior to Anti-Reflux Surgery
PR Newswire - Tue Oct 28, 11:45AM CDT
Mauna Kea Technologies (Euronext : MKEA FR0010609263) and Coliseum Northside Hospital, an HCA hospital, today announced that surgeons at Coliseum Northside Hospital are among the first in the U.S. to use an advanced endomicroscopy technology called Cellvizio to identify pre-cancerous and cancerous cells in patients gastroesophageal reflux disease (GERD). According to guidelines established by the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), it is important to take steps to identify and treat pre-cancerous or cancerous cells prior to anti-reflux surgery.

Mauna Kea Technologies: Physicians Using Optical Biopsy with Cellvizio Discover a New Diagnostic Criterion Specific for Benign Pancreatic Cysts and Invisible with Other Imaging Technologies
Business Wire - Tue Oct 21, 11:51AM CDT
--Findings from prospective multicenter CONTACT 1 study published in peer-reviewed journal Endoscopy.

Mauna Kea Technologies : Success and Strong Attendance for Cellvizio at the Annual Chinese Conference of Digestive Endoscopy, Ccdd 2014
Business Wire - Mon Oct 13, 11:07AM CDT
--Several speakers presented the clinical benefits of Cellvizio then demonstrated it in a live procedure performed in front of an audience of over 2,500 Chinese physicians

Mauna Kea Technologies Announces That the French High Authority for Health Has Given a Favorable Opinion for the Inscription of Optical Endomicroscopy for Barrett's Esophagus on the List of Reimbursable Procedures
Business Wire - Mon Oct 13, 10:59AM CDT
Regulatory News:

Mauna Kea Technologies: Major Success for Cellvizio at the EUS 2014 Conference
Business Wire - Tue Sep 23, 11:26AM CDT
--Cellvizio's clinical value for the management of pancreatic cysts was presented by several speakers and then demonstrated during two live medical procedures to the audience of 650 physicians

Mauna Kea Technologies Receives 510(K) Regulatory Clearance from U.S. FDA for New Cellvizio System Functioning in a near-Infrared Wavelength
Business Wire - Tue Jul 29, 10:45AM CDT
--New clearance is an important step on the company's product roadmap

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 85

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Weatherford Adds Grant Roach to Its Sports Deal Team

Updated Category News Views 69

Sports investing has reached that awkward middle age where everybody sees the runway, but few can explain exactly where the bumps are. Weatherford Capital’s decision to bring Grant Roach aboard as vice president is not a headline packed with transaction fireworks. It is, however, a pretty clear tell: the Tampa firm intends to put more bodies and more underwriting muscle...

Continue Reading
DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 68

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
Century's Florence Model Openings Put Arizona in Focus

Updated Category News Views 62

Six furnished houses in Florence may sound like a modest ribbon-cutting, but homebuilding is a business of small field signals before the quarterly numbers ever show up. Century Communities is scheduled to host a November grand opening for six model homes spanning two new communities in Florence, Arizona. For investors tracking NYSE:CCS, that is not a thesis by itself. It...

Continue Reading
ActivTrak's Fast 500 Rank Needs Investor Perspective

Updated Category News Views 60

Rank 488 is the sort of trophy that deserves a raised eyebrow, not confetti. ActivTrak made Deloitte's 2026 Technology Fast 500 after posting 101.1% revenue growth from 2022 through 2025, its sixth appearance on the list since 2020. That is real progress, and repeat recognition says this was not a one-quarter sugar high. Still, a Fast 500 ranking is a growth screen, not a...

Continue Reading
LG Channels UAE Push Tests the Free Streaming Model

Updated Category News Views 137

A television's idle screen is turning into contested real estate in the UAE. LG Channels is adding programming from Rakuten TV, Stingray and Red Bull TV to its free, ad-supported service, and that matters for more than somebody hunting a movie after dinner. This is a practical push to make webOS-powered screens more useful, more frequently used and, eventually, more...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 99

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading
Luxor Targets Device Chaos With Kwik IQ Hub Lockers

Updated Category News Views 86

A dead scanner at shift change can make an expensive digital rollout look downright foolish. Luxor Workspaces is aiming squarely at that unglamorous mess with its newly available Kwik IQ Hub smart-locker collection, introduced at the Connected Worker: Manufacturing Summit in Chicago on October 13–15. The pitch is not flashy: put shared radios, scanners, headsets,...

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 58

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading
Novo and nference Push Whole-Body Data Into Research

Updated Category News Views 89

Cardiometabolic medicine has spent too long staring at single numbers while the rest of the body keeps waving its arms. Novo Nordisk’s newly announced collaboration with nference is an attempt to widen that lens, combining Novo’s clinical-trial research with nference’s AI technology and federated healthcare data network. The target is not small: obesity, diabetes,...

Continue Reading

Top 5 Most Recently Viewed Articles

OFG Bancorp Reports Stellar Growth in 2024 Financial Results

Updated Category News Views 221

OFG Bancorp's Impressive Financial Results for 2024 OFG Bancorp (NYSE: OFG), the financial holding company for Oriental Bank, has reported robust financial performance for the fourth quarter and full year ended December 31, 2024. This remarkable growth marks an important milestone as the bank continues to enhance its services and strengthen its market positioning. Fourth...

Continue Reading
Innovative Dose Escalation Strategy for Infliximab Therapy

Updated Category News Views 404

Innovative Dose Escalation Strategy for Infliximab Therapy Celltrion, a prominent biopharmaceutical company based in Incheon, South Korea, recently unveiled exciting findings regarding the two-year efficacy of dose escalation therapy with subcutaneous infliximab, known as CT-P13 SC. These results were announced at the United European Gastroenterology (UEG) Week 2024. The...

Continue Reading
Understanding the Impact of Rising Repo Activity on Funding

Updated Category News Views 228

The Rising Repo Activity and Its Implications The recent rise in overnight repurchase agreements, commonly referred to as repos, has significantly influenced the financial landcape. This surge has put immense stress on banks that serve as intermediaries in these transactions, creating potential funding pressures at crucial periods such as quarter-ends and year-ends. What...

Continue Reading
Recent Lawsuit Over Securities at Perpetua Resources Corp. Highlights Shareholder Rights

Updated Category News Views 158

Understanding the Class Action Lawsuit Against Perpetua Resources Corp Levi & Korsinsky, LLP is raising awareness about a class action lawsuit impacting shareholders of Perpetua Resources Corp. This initiative is crucial for investors who experienced losses due to alleged securities fraud associated with the company's operations. Class Definition and Purpose The lawsuit...

Continue Reading
Exciting New Pickleball Kingdom Facility Set for Kentucky

Updated Category News Views 617

Exciting Announcement for Pickleball Enthusiasts Pickleball Kingdom, recognized as the world's largest indoor pickleball organization, is thrilled to announce its latest facility opening in Lexington, Kentucky. With a plan to cover an impressive 42,300 square feet, this state-of-the-art venue will feature 17 professional-grade indoor courts designed to deliver an ultimate...

Continue Reading